COMPOSICION FARMACEUTICA DE AZIMILIDINA QUE COMPRENDE 0,5% A APROXIMADAMENTE 2,5% (W/W) DE AGUA; Y USO PARA EL TRATAMIENTO DE ARRITMIAS CARDIACAS.

摘要

The present invention is directed to solvates and various polymorphic forms of (E)-1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione dihydrochloride and pharmaceutical compositions thereof.